ArticleJournal of ovarian research2025

A comparative analysis of tumor markers reveals EDA fibronectin as a promising target in high-grade serous ovarian cancer.

Alessia Piermattei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.